Hexamine (Hexamethylenetetramine) from China Injures U.S. Industry, Says USITC
Hexamine (Hexamethylenetetramine) from China Injures U.S. Industry, Says USITC
The U.S. International Trade Commission Commission (Commission or USITC) today determined that a U.S. industry is materially injured by reason of imports of hexamine (hexamethylenetetramine) from China that the U.S. Department of Commerce (Commerce) has determined are sold in the United States at less than fair value and subsidized by the government of China.
Chair Amy Karpel and Commissioner Jason E. Kearns made affirmative determinations of present material injury. Commissioner David S. Johanson made affirmative threat determinations.
As a result of the Commission’s affirmative determinations, Commerce will issue a countervailing duty order and an antidumping duty order on imports of these products from China.
The Commission’s public report, Hexamine (Hexamethylenetetramine) from China (Inv. Nos. 701-TA-737 and 731-TA-1712 (Final), USITC Publication 5660, August 2025), will contain the views of the Commission and information developed during the investigations.
The report will be available by September 16, 2025; when available, it may be accessed on the USITC website.
Status of proceedings, links to relevant documents, and more information about these investigations can be found at the Commission’s Investigations Database System (IDS).